Daily News Podcast

FDA approves Zephyr valves for emphysema


 

The Food and Drug Administration has approved the Zypher endobronchial valve system for patients with severs emphysema who are experiencing difficulty breathing. Also today, meth use is climbing alongside the opioid epidemic, pain remains after rheumatoid arthritis diagnosis, and higher RA biologic drug levels linked with more infections. Subscribe to the MDedge Daily News for today’s top news.

Recommended Reading

JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Dermatology
Patients going without as insulin prices skyrocket
MDedge Dermatology
Chilblain Lupus Erythematosus Presenting With Bilateral Hemorrhagic Bullae of Distal Halluces
MDedge Dermatology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Dermatology
Opioids do more harm than good for musculoskeletal pain
MDedge Dermatology
Adalimumab strikes out for aortic inflammation in psoriasis
MDedge Dermatology
Addiction: Veterans with pain, opioid use disorder
MDedge Dermatology
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Dermatology
Medicare beneficiaries are dying differently
MDedge Dermatology
Updated anthrax vaccine recommendations
MDedge Dermatology